Transplantation
253 articles · 8 journals
Journals in this subcategory (8)
- Transplantation Proceedings · Elsevier (86)
- Cytotherapy · Elsevier (58)
- Transplant Immunology · Elsevier (44)
- Pediatric Transplantation · Wiley (30)
- Clinical Transplantation · Wiley (21)
- Bone Marrow Transplantation · Springer Nature (8)
- Xenotransplantation · Wiley (6)
- Renal Replacement Therapy · Springer Nature (0)
- Key Considerations for In Vitro Assessment of On- and Off-target/ Off-Disease Effects of Chimeric Antigen Receptor T-Cell Therapies
- Functional assessment reveals the properties of ABCG2-positive limbal stem cells derived from human pluripotent stem cells
- Cord blood regulatory T cells outperform adult and thymus Tregs in therapeutic potential for next-generation cell therapy
- Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research
- In vitro and in vivo antibacterial activity of the mesenchymal stem cell secretome against Escherichia coli colonization among infants
- Establishment and multisite evaluation of a MOLT-4 cell-based IL-2-independent growth assay to detect transformed cells in T-cell products
- iPSC-derived engineered immune cells: a therapeutic platform
- Compassionate and Emergency Use Cellular Therapy Products: Regulatory, Operational, and Quality Considerations
- Rapid epigenetic analysis for quantification of iPSC pluripotency from dried cell spots
- NIVOLUMAB-CONTAINING SALVAGE CHEMOTHERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA MAY IMPAIR STEM CELL MOBILIZATION
- A Genetically Engineered, Monoclonal, and Inducible Mesenchymal Stem Cell Platform with Controlled Proliferation and In Vivo Traceability
- Enhancing NK cell cytotoxicity with innate cell engagers as an alternative to CAR-NK cells
- Long-term 3D tumor spheroid cultures enable evaluation of durable effector T cell function in solid tumors
- IMPACT OF RUXOLITINIB ON VIRUS SPECIFIC-T LYMPHOCYTES: AN IN VITRO STUDY
- Comparative Analysis of Regulatory Pathways in Regenerative Medicine: A Benchmark Study of Japan’s Act on the Safety of Regenerative Medicine (ASRM) against Eight Asia-Pacific Jurisdictions
- Aims and Scope
- Editorial Board
- Subscription information
- Table of Contents
- A regulatory gap: addressing visible particle control in cell and gene therapies through a risk-based framework
- Comparative analysis of advanced therapy regulatory frameworks in Latin America: perspectives from the ISCT South and Central America Legal and Regulatory Affairs Committee
- Swissmedic Innovation Office: early regulatory engagement to accelerate ATMP clinical development—regulatory insights and recommendations
- Enhanced antitumor efficacy through combined chimeric antigen receptor T cell therapy and CD40 stimulation in syngeneic solid tumor models
- Hypoxia during GPC2-CAR T-cell manufacturing compromises cell expansion and cytotoxic capacity
- Early detection of chimeric antigen receptor-T-associated neurotoxicity via cytokine monitoring in serum
- Pre-clinical validation of OSCAR-3 mRNA-based CAR T cells for targeting osteosarcomas
- Pretransplant infection associated with inferior survival after TCRαβ/CD19-depleted haploidentical HSCT in pediatric nonmalignant disorders
- Multi-site validation and applicability assessment of a practical three-dimensional colony formation assay for detecting malignantly transformed cells
- Evaluation of pluripotent stem cell-derived myeloid line-based chimeric antigen receptor macrophage-like cells identifies limited in vivo persistence
- Integrated T-cell enrichment, static transduction, and expansion in gas-permeable bioreactors for adoptive cell therapy